Suppression of COVID-19 outbreak in the municipality of Vo’, Italy

Enrico Lavezzo, Elisa Franchin, Constanze Ciavarella, Gina Cuomo-Dannenburg, Luisa Barzon, Claudia Del Vecchio, Lucía Rossi, Riccardo Manganelli, Arianna Loregian, Nicolò Navarin, Davide Abate, Manuela Sciro, Stefano Merigliano, Ettore Decanale, Maria Cristina Vanuzzo, Francesca Saluzzo, Francesco Onelia, Monia Pacenti, Saverio Giuseppe Parisi, Giovanni Carretta, Daniele Donato, Luciano Flor, Silvia Cocchio, Giulia Masi, Alessandro Sperduti, Lorenzo Cattarino, Renato Salvador, Katy A. M. Gaythorpe, Alessandra Rosalba Brazzale, Stefano Toppo, Marta Trevisan, Vincenzo Baldo, Christl A. Donnelly, Neil M. Ferguson, Ilaria Dorigatti, Andrea CrisantimedRxiv 2020 · DOI

Abstract

In February 2020, the municipality of Vo’, Italy, became the site of one of the earliest and most comprehensive epidemiological studies of the SARS-CoV-2 pandemic. Following the first recorded COVID-19 death in Italy, local authorities implemented a total lockdown and conducted two rounds of mass testing covering the vast majority of the population. This study reveals that nearly half of all infections were asymptomatic and that these individuals carried viral loads comparable to symptomatic patients. Despite this silent spread, the intervention successfully suppressed the outbreak, reducing the effective reproduction number ($R_t$) from 3.0 to 0.14.

Introduction

The early stages of the COVID-19 pandemic were characterized by significant uncertainty regarding the prevalence of asymptomatic infection and its role in transmission. If a large portion of the population could spread the virus without showing symptoms, traditional control measures based on clinical presentation would be insufficient. The small town of Vo’, near Padua, provided a unique "natural laboratory" to investigate these dynamics. Following a 14-day lockdown and exhaustive testing, researchers were able to quantify the asymptomatic reservoir and evaluate the efficacy of strict social distancing and contact tracing.

Methodology and Data Collection

The study utilized two cross-sectional surveys conducted at the beginning and end of the 14-day lockdown. The first survey reached 85.9% of the population (2,812 individuals), while the second reached 71.5% (2,343 individuals).

Testing was performed via nasopharyngeal swabs and RT-PCR analysis targeting the E and RdRp genes. To estimate viral load, the researchers analyzed cycle threshold (Ct) data, which serves as a proxy for the amount of viral genetic material present. This allowed for a direct comparison between different clinical groups. Additionally, a Bayesian SEIR (Susceptible-Exposed-Infectious-Removed) model was employed to estimate transmission parameters, supplemented by manual contact tracing to reconstruct infection chains.

The Role of Asymptomatic Carriers

One of the most striking findings was the prevalence of asymptomatic cases. Across both surveys, 43.2% (95% CI 32.2-54.7%) of confirmed SARS-CoV-2 infections were asymptomatic, meaning the individuals never developed symptoms during the study period.

Crucially, the study found no statistically significant difference in the viral loads of symptomatic and asymptomatic individuals. This parity suggests that asymptomatic carriers possess the same potential to shed the virus and contribute to transmission as those with clinical symptoms. Contact tracing data supported this, showing that new infections during the lockdown often originated from asymptomatic household members or community contacts established just prior to the restrictions.

Impact of the Intervention

The combination of mass testing and lockdown proved highly effective. The prevalence of infection in Vo’ dropped from 2.6% at the start of the lockdown to 1.2% by its conclusion. The modeling data indicated a dramatic collapse in the weekly effective reproduction number ($R_t$), which fell from an initial 3.0 to 0.14.

Other key epidemiological metrics included:

  • Serial Interval: The mean time between successive cases in a transmission chain was 6.9 days.
  • Viral Clearance: The average time to test negative was 9.3 days.
  • Hospitalization: 17.2% of positive cases required hospital care, with the highest risk observed in the 71-80 age bracket.

Demographic Observations

The study noted a peculiar trend regarding younger residents: no children under the age of 10 tested positive for SARS-CoV-2, despite living in households with infected adults. While this suggests a potential difference in infection dynamics or resistance in children, the authors caution that the study only measured active viral shedding at specific time points, not cumulative exposure.

Conclusion

The Vo’ study demonstrates that asymptomatic SARS-CoV-2 infections are common and carry significant viral loads, making them a major driver of transmission. However, it also provides a blueprint for successful outbreak suppression. By combining mass testing—which identifies the "silent" asymptomatic reservoir—with strict lockdown measures and contact tracing, it is possible to rapidly reduce the reproduction number and clear the virus from a localized population. These findings underscore the necessity of testing strategies that go beyond symptomatic individuals to effectively control the spread of COVID-19.

Summary updated

Abstract

Abstract On the 21 st of February 2020 a resident of the municipality of Vo’, a small town near Padua, died of pneumonia due to SARS-CoV-2 infection 1 . This was the first COVID-19 death detected in Italy since the emergence of SARS-CoV-2 in the Chinese city of Wuhan, Hubei province 2 . In response, the regional authorities imposed the lockdown of the whole municipality for 14 days 3 . We collected information on the demography, clinical presentation, hospitalization, contact network and presence of SARS-CoV-2 infection in nasopharyngeal swabs for 85.9% and 71.5% of the population of Vo’ at two consecutive time points. On the first survey, which was conducted around the time the town lockdown started, we found a prevalence of infection of 2.6% (95% confidence interval (CI) 2.1-3.3%). On the second survey, which was conducted at the end of the lockdown, we found a prevalence of 1.2% (95% CI 0.8-1.8%). Notably, 43.2% (95% CI 32.2-54.7%) of the confirmed SARS-CoV-2 infections detected across the two surveys were asymptomatic. The mean serial interval was 6.9 days (95% CI 2.6-13.4). We found no statistically significant difference in the viral load (as measured by genome equivalents inferred from cycle threshold data) of symptomatic versus asymptomatic infections (p-values 0.6 and 0.2 for E and RdRp genes, respectively, Exact Wilcoxon-Mann-Whitney test). Contact tracing of the newly infected cases and transmission chain reconstruction revealed that most new infections in the second survey were infected in the community before the lockdown or from asymptomatic infections living in the same household. This study sheds new light on the frequency of asymptomatic SARS-CoV-2 infection and their infectivity (as measured by the viral load) and provides new insights into its transmission dynamics, the duration of viral load detectability and the efficacy of the implemented control measures.
BibTeX
@misc{lavezzo2020suppression,
  author = {Enrico Lavezzo and Elisa Franchin and Constanze Ciavarella and Gina Cuomo-Dannenburg and Luisa Barzon and Claudia Del Vecchio and Lucía Rossi and Riccardo Manganelli and Arianna Loregian and Nicolò Navarin and Davide Abate and Manuela Sciro and Stefano Merigliano and Ettore Decanale and Maria Cristina Vanuzzo and Francesca Saluzzo and Francesco Onelia and Monia Pacenti and Saverio Giuseppe Parisi and Giovanni Carretta and Daniele Donato and Luciano Flor and Silvia Cocchio and Giulia Masi and Alessandro Sperduti and Lorenzo Cattarino and Renato Salvador and Katy A. M. Gaythorpe and Alessandra Rosalba Brazzale and Stefano Toppo and Marta Trevisan and Vincenzo Baldo and Christl A. Donnelly and Neil M. Ferguson and Ilaria Dorigatti and Andrea Crisanti},
  title = {{Suppression of COVID-19 outbreak in the municipality of Vo’, Italy}},
  year = {2020},
  doi = {10.1101/2020.04.17.20053157},
  howpublished = {medRxiv},
}
Figure